World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website http://www.wjon.org

Original Article

Volume 5, Number 2, April 2014, pages 55-61


Male Breast Cancer and Hyperestrogenemia: A Thirteen-Year Review

Figures

Figure 1.
Figure 1. Comparison of the general characteristics of the study population between extensive and non-extensive stages of MBC.
Figure 2.
Figure 2. Comparison of the prevalence of high estrogen indicators in the study population between extensive and non-extensive stages of MBC.

Tables

Table 1. Comparison of the General Characteristics of the Study Population Between Extensive and Non-Extensive Stages of Male Breast Cancer, Percentages Are Included in Parenthesis
 
Stage 0-2 (%)Stage 3-4 (%)P value
Race0.455
  Black2 (100)0 (0)
  White4 (40)6 (60)
Family history1
  Negative3 (60)2 (40)
  Positive3 (60)2 (40)
Smoking1
  No3 (50)3 (50)
  Yes3 (60)2 (40)
Laterality1
  Right1 (33.3)2 (66.6)
  Left5 (55.5)4 (44.4)
HER/NEU0.167
  Negative5 (71.4)2 (28.5)
  Positive0 (0)3 (100)
ER1
  Negative0 (0)1 (100)
  Positive6 (54.5)5 (45.4)
PR1
  Negative2 (50)2 (50)
  Positive4 (50)4 (50)
Mass on PE1
  No1 (50)1 (50)
  Yes4 (50)4 (50)
Low HDL0.143
  No1 (25)3 (75)
  Yes3 (100)0 (0)
Low albumin1
  No3 (50)3 (50)
  Yes2 (50)2 (50)
BMI1
  Normal1 (50)1 (50)
  Obese5 (55.5)4 (44.4)
High estrogen score1
  None0 (0)1 (100)
  At least one5 (45.5)6 (54.5)

 

Table 2. Summary of the Treatment Received for Male Breast Cancer, Summarized by Cancer Stage
 
Stage 0-2 (Less extensive group)Stage 3-4 (More extensive group)
Surgery
  No24
  Yes32
Beam radiation
  No22
  Yes33
Chemotherapy
  No23
  Yes31
Hormonal therapy
  No22
  Yes43